Presentation is loading. Please wait.

Presentation is loading. Please wait.

Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era

Published byWarren Norton Modified over 5 years ago

Similar presentations

Presentation on theme: "Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era"— Presentation transcript:

1 Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era
Karen J. Dickinson, MBBS FRCS (Engl), Kenneth Wang, MD, Lizhi Zhang, MD, Mark S. Allen, MD, Stephen D. Cassivi, MD, MS, Francis C. Nichols, MD, Robert Shen, MD, Dennis A. Wigle, MD, PhD, Shanda H. Blackmon, MD, MPH  The Annals of Thoracic Surgery  Volume 103, Issue 3, Pages (March 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Overall survival in the cohort of patients with cT1 esophageal adenocarcinoma undergoing endoscopic mucosal resection and then esophagectomy. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Patients with a moderate risk (blue line) of lymph node metastases (LN mets) on preoperative scoring have poorer 5-year survival (54%) than high-risk (red line) patients (84% survival; p = 0.04). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Patients with lymph nodes involved (red line) at the time of esophagectomy had decreased 5-year survival of 51% compared with 84% in lymph node-negative patients (blue line; p = 0.04). The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Esophagectomy Outcomes in the Endoscopic Mucosal Resection Era"

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S
Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S

Usman Ahmad, MD, Zuoheng Wang, PhD, Ayesha S
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.

Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Benny Weksler, MD, Jennifer L. Sullivan, MD 

Benny Weksler, MD, Jennifer L. Sullivan, MD 
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Andrew C. Chang, MD, Andrzej S. Kosinski, PhD, Daniel P

Andrew C. Chang, MD, Andrzej S. Kosinski, PhD, Daniel P
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.

Extended Pleurectomy-Decortication–Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years  Joseph.
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Christopher W. Seder, MD, Mark S. Allen, MD, Francis C

Christopher W. Seder, MD, Mark S. Allen, MD, Francis C
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,

Super-Charged Pedicled Jejunal Interposition Performance Compares Favorably With a Gastric Conduit After Esophagectomy  Elizabeth H. Stephens, MD, PhD,

Similar presentations

Ads by Google